EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study

Yoshiro Omori, Satoshi Matsukuma, Mikiko Kawa, Kazuki Ishimitsu, Toru Kawaoka, Norio Akiyama, Kazuhisa Tokuno, Yuji Fujita, Shinya Sato, Shigeru Yamamoto

International Journal of Colorectal Disease · 2025

DOI: 10.1007/s00384-024-04798-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, 2025. Verfasst von Yoshiro Omori und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Japan Community Healthcare Organization Tokuyama Central Hospital, 1-1 Koda-Cho, Shunan, Yamaguchi, 745-0822, Japan. Hauptthemen laut MEDLINE: Trifluridine, Neutropenia, Colorectal Neoplasms, Pyrrolidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrifluridineNeutropeniaColorectal NeoplasmsPyrrolidinesAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleRetrospective StudiesRisk FactorsMiddle AgedAgedThyminePrognosisNeoplasm MetastasisDrug CombinationsAdultUracilAged, 80 and overProportional Hazards Models

Stichwörter der Autor:innen

Overall survivalRenal impairmentSevere neutropeniaTrifluridine-tipiracil

Substanzen

TrifluridinePyrrolidinesThyminetrifluridine tipiracil drug combinationDrug CombinationsUracil

Autor:innen und Institutionen

  • Department of Pharmacy, Japan Community Healthcare Organization Tokuyama Central Hospital, 1-1 Koda-Cho, Shunan, Yamaguchi, 745-0822, Japan.
  • Department of Surgery, Japan Community Healthcare Organization Tokuyama Central Hospital, 1-1 Koda-Cho, Shunan, Yamaguchi, 745-0822, Japan. s1980matsu@gmail.com.
  • Department of Surgery, Japan Community Healthcare Organization Tokuyama Central Hospital, 1-1 Koda-Cho, Shunan, Yamaguchi, 745-0822, Japan.

Zitieren

APA

Omori, Y., Matsukuma, S., Kawa, M., Ishimitsu, K., Kawaoka, T., Akiyama, N., Tokuno, K., Fujita, Y., Sato, S., & Yamamoto, S. (2025). Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-024-04798-2

Vancouver

Omori Y, Matsukuma S, Kawa M, Ishimitsu K, Kawaoka T, Akiyama N, et al. Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study. International Journal of Colorectal Disease. 2025. doi:10.1007/s00384-024-04798-2

BibTeX
@article{Omori2025,
  author = {Omori, Yoshiro and Matsukuma, Satoshi and Kawa, Mikiko and Ishimitsu, Kazuki and Kawaoka, Toru and Akiyama, Norio and Tokuno, Kazuhisa and Fujita, Yuji and Sato, Shinya and Yamamoto, Shigeru},
  title = {Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study},
  journal = {International Journal of Colorectal Disease},
  year = {2025},
  doi = {10.1007/s00384-024-04798-2}
}
Kostenlos starten →